KRAS and cancer: Organoids of engineered cells carrying mutant Apc, inducible mutant Kras, and inducible mutant Tp53, implanted orthotopically in the mouse colon, yield stage 1 cancers within 4 weeks of Cre-mediated mutant KRAS and TP53 induction [17].